Pulmonary Fibrosis Foundation Adds Two Experts to Board of Directors
The Pulmonary Fibrosis Foundation (PFF) has elected Dr. Bradford Bemiss and Dr. Krishna Thavarajah to its Board of Directors. Both are respected experts in pulmonary fibrosis and interstitial lung diseases, bringing clinical and research experience to guide the organization.
CHICAGO, July 9, 2026 – The Pulmonary Fibrosis Foundation (PFF) announced the election of Dr. Bradford Bemiss and Dr. Krishna Thavarajah to its Board of Directors. Both physicians are recognized experts in pulmonary fibrosis (PF) and interstitial lung diseases (ILD), adding significant clinical and research experience to the foundation's leadership.
The appointments come as the PFF implements its new five-year strategic plan, "The PFF is Me." This plan aims to accelerate the development of a cure for the more than 250,000 individuals in the United States living with PF and ILD. Dr. Bemiss and Dr. Thavarajah, both specializing in pulmonary and critical care medicine, are expected to play a key role in advancing the organization's mission.
Dr. Bradford Bemiss serves as an Associate Professor at Northwestern University Feinberg School of Medicine and directs the Northwestern Medicine PFF Care Center Network site. His expertise spans ILD, lung transplantation, clinical trials, and guideline development.
Dr. Krishna Thavarajah leads the Interstitial Lung Disease Program at Henry Ford Hospital and directs its PFF Care Center Network site. She brings over 15 years of experience in managing ILD programs and has been actively involved in various PFF committees.
The PFF stated that the addition of these two directors reflects its commitment to engaging leading experts to advance research, improve patient care, and support those affected by these progressive lung diseases.